Promising clinical studies surrounding Retatrutide , specifically the 120 milligram formulation branded as ZPHC, suggest a impressive impact on body mass reduction and related chronic illnesses . Scientists posit that this dual compound, influencing both GLP-1 and GIP pathways , could provide a